Overall, these results demonstrate that T cells expressing the chemokine receptor CX3CR1 show increased homing towards tumors producing the specific ligand, and highlight the critical issue of a gradient between peripheral tissues and the tumor. This evidence concerns the gene CX3CR1 and neoplasm.